Skye Bioscience, Inc. (SKYE) - Quarterly Income Statement

Home
SKYE
Financials

1.74 (USD) • At close November 17, 2023

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1	2015 Q4	2015 Q3	2015 Q2	2015 Q1	2014 Q4	2014 Q3	2014 Q2	2014 Q1	2013 Q4	2013 Q3	2013 Q2	2013 Q1	2012 Q4	2012 Q3	2012 Q2	2012 Q1
Revenue Numbers are in millions	0	0	0	0	0.163	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.071	0.073	0.063	0.083	0.091	0.109	0.057	0.016	0	0
Cost of Revenue Numbers are in millions	0	0	0	0	0	0.029	0.034	0.033	0.032	0.029	0.028	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.18	0	0.019	0.024	0.021	0.031	0.032	0.044	0.025	0.005	0	0
Gross Profit Numbers are in millions	0	0	0	0	0.163	-0.029	-0.034	-0.033	-0.032	-0.029	-0.028	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.18	0	0.052	0.049	0.043	0.052	0.059	0.065	0.033	0.011	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.727	0.676	0.676	0.622	0.65	0.6	0.57	0.67	0	0
Reseach & Development Expenses Numbers are in millions	7.793	4.883	4.079	1.946	1.591	1.255	1.788	1.185	1.537	1.782	1.427	1.266	1.113	0.328	0.881	0.61	0.37	0.346	0.429	0.8	0.716	0.513	0.688	0.321	0.238	0.067	0	0.025	0.07	0.089	0.061	0.092	0.263	0.081	0.46	0.135	0.343	0.152	0.043	0.037	0.033	0.195	0	0	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	4.554	4.639	4.327	4.206	2.495	2.236	1.206	1.915	1.54	1.141	1.791	1.622	1.348	1.491	0.949	1.128	0.949	1.192	0.792	1.412	1.128	0.99	1.083	1.194	1.078	0.978	1.08	1.226	0.917	0.673	0.67	1.288	0.649	0.776	1.022	1.085	0.811	0.744	1.313	0.873	1.669	0.663	0.033	0.046	0.03	0.049	0.039	0.04	0.029	0.006	0	0.001
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	-0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	4.554	4.639	4.327	4.206	2.495	2.236	1.206	1.915	1.54	1.141	1.791	1.622	1.348	1.491	0.949	1.128	0.949	1.192	0.792	1.412	1.128	0.99	1.083	1.194	1.078	0.978	1.08	1.226	0.917	0.673	0.67	1.288	0.649	0.776	1.022	1.085	0.811	0.744	1.313	0.873	1.669	0.663	0.033	0.046	0.03	0.049	0.039	0.04	0.029	0.006	0	0.001
Other Expenses Numbers are in millions	-1.681	-4.553	0	0	0	21.215	-0.152	0	6.205	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.014	0.017	0.014	0.008	0.019	0.022	0.01	0	0	0
Operating Expenses Numbers are in millions	10.666	4.969	8.406	6.152	4.086	24.706	2.843	3.1	9.283	2.922	3.218	2.888	2.462	1.819	1.83	1.737	1.319	1.538	1.221	2.211	1.844	1.503	1.771	1.515	1.315	1.046	1.08	1.251	0.987	0.762	0.731	1.38	0.912	0.856	1.482	1.22	1.154	0.896	1.357	0.91	1.701	0.858	0.048	0.063	0.044	0.057	0.059	0.062	0.039	0.006	0	0.001
Operating Income Numbers are in millions	-10.666	-3.898	-8.406	-6.152	-4.086	-24.706	-2.995	-3.1	-9.283	-2.922	-3.218	-2.888	-2.462	-1.819	-1.83	-1.737	-1.319	-1.538	-1.221	-2.211	-1.844	-1.503	-1.771	-1.515	-1.315	-1.046	-1.08	-1.251	-0.987	-0.762	-0.731	-1.38	-0.912	-0.856	-1.482	-1.22	-1.154	-0.896	-1.357	-0.91	-1.701	-0.858	0.004	-0.013	-0.001	-0.005	0.001	0.004	-0.006	0.005	-0	-0.001
Operating Income Ratio Numbers are in millions	0	0	0	0	-25.009	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.057	-0.184	-0.019	-0.064	0.008	0.033	-0.108	0.293	0	0
Total Other Income Expenses Net Numbers are in millions	0.92	0	0.511	1.135	-0.334	-0.24	-0.113	-2.067	-0.607	-0.205	-0.196	-0.155	-0.051	-0.006	-0.193	-0.423	-0.183	0.242	-0.198	-0.13	6.696	-3.428	17.678	-13.259	-4.907	-1.051	-1.58	-6.962	0.358	0.281	0.03	0.098	-0.208	-0.089	2.056	-0.465	0.464	-0.286	-0.7	0	0	0	0.004	-0	0.005	-0	-0.002	-0	0.006	0	0	0
Income Before Tax Numbers are in millions	-9.746	-3.898	-7.895	-5.018	-4.42	-24.946	-3.108	-5.168	-9.89	-3.127	-3.414	-3.043	-2.512	-1.825	-2.022	-2.161	-1.502	-1.297	-1.419	-2.342	4.852	-4.931	15.907	-14.774	-6.222	-2.096	-2.66	-8.214	-0.629	-0.48	-0.701	-1.282	-1.12	-0.945	0.573	-1.685	-0.691	-1.182	-2.057	-0.91	-1.701	-0.858	0.008	-0.014	0.004	-0.006	-0.002	0.003	0	0.005	0	-0
Income Before Tax Ratio Numbers are in millions	0	0	0	0	-27.052	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.109	-0.186	0.057	-0.067	-0.017	0.029	0.004	0.302	0	0
Income Tax Expense Numbers are in millions	0	0	0.008	0.002	0	0	0.004	0	0.002	0	0.005	0	0.001	0	0.002	0	0	0	0.002	0	0	0	0.002	0	0	1.051	0.002	0	-0.001	0	0.002	0.001	0	0	0	0	0	0.001	0	0	0.002	0.001	0	0	0	-0	-0.001	0.001	0	0	0	0
Net Income Numbers are in millions	-9.746	-3.898	-7.903	-5.02	-4.42	-24.946	-3.112	-5.168	-9.892	-3.127	-3.419	-3.043	-2.513	-1.825	-2.024	-2.161	-1.502	-1.297	-1.42	-2.342	4.852	-4.931	15.905	-14.774	-6.222	-2.096	-2.662	-8.214	-0.628	-0.48	-0.703	-1.283	-1.12	-0.945	0.573	-1.685	-0.691	-1.183	-2.057	-0.91	-1.703	-0.859	0.008	-0.014	0.004	-0.005	-0.001	0.002	0	0.005	0	-0
Net Income Ratio Numbers are in millions	0	0	0	0	-27.052	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.109	-0.186	0.057	-0.062	-0.008	0.019	0.003	0.287	0	0
EPS Numbers are in millions	-0.24	-0.1	-0.2	-0.18	-0.36	-3.17	-0.8	-1.37	-4.99	-1.58	-1.72	-1.61	-1.52	-1.1	-1.34	-1.6	-1.46	-1.26	-1.94	-3.21	9.12	-9.27	30	-27.5	-11.83	-3.99	-5.09	-23.17	-5.2	-3.98	-6.19	-13.8	-14.07	-11.87	7.5	-20	-10.13	-17.33	-31.62	-14.02	-40.53	-20	0.23	-0.4	0.11	-0.15	-0.021	0.061	0.006	0.14	0.002	-0.011
EPS Diluted Numbers are in millions	-0.24	-0.1	-0.2	-0.18	-0.36	-3.17	-0.8	-1.37	-4.99	-1.58	-1.72	-1.61	-1.52	-1.1	-1.34	-1.6	-1.46	-1.26	-2.5	-2.5	9.12	-10	20	-27.5	-11.83	-5	-5	-22.5	-5.2	-5	-5	-13.8	-14.07	-12.5	7.5	-20	-10.13	-17.33	-31.62	-15	-40.53	-20	0.23	-0.4	0.11	-0.15	-0.021	0.061	0.006	0.14	0.002	-0.011
EBITDA Numbers are in millions	-9.618	-3.541	-7.422	-4.553	-4.058	-24.622	-2.961	-3.067	-9.808	-2.893	-3.191	-2.861	-2.269	-1.812	-1.829	-1.736	-1.316	-1.114	-1.247	-2.175	3.438	-4.636	16.198	-14.658	-6.165	-2.096	-2.66	-8.176	-0.635	-0.478	-0.699	-1.28	-0.909	-0.852	-1.478	-1.217	-1.152	-0.894	-1.354	-0.908	-1.699	-0.858	0.012	-0.011	0.006	-0.003	0.003	0.008	0.001	0.005	0	-0
EBITDA Ratio Numbers are in millions	0	0	0	0	-24.836	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.164	-0.149	0.101	-0.03	0.033	0.07	0.022	0.302	0	0

Skye Bioscience, Inc.

OTC:SKYE Add to watchlist

OTC:SKYE